Experienced in Urinary Tract Infection (UTI)

Marco J. Schnabel

Caritas St. Josef Medical Center, Landshuter Str. 65, 
Regensburg, BY, DE 
Experienced in Urinary Tract Infection (UTI)
Caritas St. Josef Medical Center, Landshuter Str. 65, 
Regensburg, BY, DE 
OverviewLocationsClinical Research

Overview

Marco Schnabel practices in Regensburg, Germany. Mr. Schnabel is rated as an Experienced expert by MediFind in the treatment of Urinary Tract Infection (UTI). His top areas of expertise are Kidney Stones, Urinary Tract Infection (UTI), Urothelial Cancer, Lithotripsy, and Osteotomy.

His clinical research consists of co-authoring 38 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Urinary Tract Infection (UTI).

Gender
Male

Locations

Caritas St. Josef Medical Center, Landshuter Str. 65, Regensburg, BY 93053, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations (PROOF 302)
Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations (PROOF 302)
Enrollment Status: Terminated
Publish Date: March 13, 2024
Intervention Type: Drug
Study Drug: Infigratinib
Study Phase: Phase 3

38 Total Publications

Real-world Evidence from a Retrospective Multicentre Analysis on First-line Therapy for Metastatic Papillary Renal Cell Carcinoma. A GUARDIANS Project.
Real-world Evidence from a Retrospective Multicentre Analysis on First-line Therapy for Metastatic Papillary Renal Cell Carcinoma. A GUARDIANS Project.
Journal: European urology open science
Published: June 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Schnabel's expertise for a condition
ConditionClose
      View All 14 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile